Alto Neuroscience Newsroom

Alto Neuroscience Analyst Ratings

BenzingaNov 13 10:20 ET

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Cuts Target Price to $10

Moomoo NewsNov 13 08:31 ET

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Moomoo NewsNov 13 06:31 ET

Alto Neuroscience Stock Crashes Amid Failed Study, Wedbush Downgrade

Seeking AlphaOct 23 10:56 ET

Wedbush Downgrades Alto Neuroscience to Neutral Following ALTO-100 Readout

TipRanksOct 23 08:34 ET

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsOct 23 08:31 ET

Alto Neuroscience Is Maintained at Outperform by Baird

Dow JonesOct 23 07:35 ET

Alto Neuroscience Analyst Ratings

BenzingaOct 23 07:25 ET

Alto Neuroscience Downgraded to Neutral From Buy at Rodman & Renshaw

TipRanksOct 23 06:57 ET

Baird Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsSep 11 03:31 ET

Buy Rating Affirmed for Alto Neuroscience, Inc. Amid Promising ALTO-100 Clinical Developments

TipRanksSep 11 02:40 ET

Alto Neuroscience Analyst Ratings

BenzingaSep 10 08:52 ET

Wedbush Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsSep 10 08:31 ET

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Moomoo NewsSep 10 07:31 ET

Analysts Are Bullish on These NA Stocks: Alto Neuroscience, Inc. (ANRO), Rubrik, Inc. Class A (RBRK)

TipRanksSep 10 07:23 ET

Wedbush Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $29

Moomoo NewsSep 4 06:34 ET

Jefferies Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsAug 26 10:31 ET

Alto Neuroscience, Inc. (ANRO) Gets a Buy From Jefferies

TipRanksAug 26 09:54 ET

Buy Rating Affirmed for Alto Neuroscience, Inc. on Strong Clinical Trials and Strategic Precision Neuroscience Approach

TipRanksAug 16 02:29 ET

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Moomoo NewsAug 15 08:31 ET